"Compared to the reality of the drug industry, my book reads like a vacation post card"
- John le Carré, Author of The Constant Gardner
 
Top News arrow Drug Safety Issues arrow UK-MHRA Drug-Related Suicide Reports_Yellow Card
UK-MHRA Drug-Related Suicide Reports_Yellow Card Print E-mail
Wednesday, 01 March 2006
The UK adverse event drug reporting system utilizes the Yellow Card system for filing reports.

 It is estimated to represent 1 in 100 adverse drug events that occur. However, as there is no control, the number of incidents do not inform us about the rate at which these events occured or possible contributing factors other than the drug.

 

 SUICIDE ACCOMPLISHED             MHRA stats from Yellow Cards       2004

 

Drug Substance

No of Reports

1          fluoxetine

62

2          paroxetine

38

3          clozapine

27

4          venlafaxine

17

= 5       sertraline

15

= 5       isotretinoin

15

=7        citalopram

9

=7        dothiepin

9

=7        moclobemide

9

= 10     risperidone

8

= 10     zopiclone

8

12        olanzapine

7

= 13     amitriptyline

6

= 13     mefloquine

6

= 13     quetiapine

6

= 16     fluphenazine

5

= 16     fluvoxamine

5

= 18     bupropion

4

= 18     diazepam

4

= 18     thioridazine      

4

 

 

NON-ACCIDENTAL OVERDOSE

 

Drug Substance

No of Reports

1          paroxetine

36

2          olanzapine

29

= 3       paracetamol

28

= 3       venlafaxine

28

= 5       bupropion

17

= 5       clozapine

17

= 5       fluoxetine

17

8          sertraline

15

9          citalopram

14

= 10     carbamazepine 

9

= 10     codeine           

9

=12      amitriptyline

8

=12      dothiepin

8

=12      zopiclone

8

=12      dextropropoxyphene

8

16        quetiapine

7

17        moclobemide

6

 

                         

OVERDOSE N.O.S.

 

Drug Substance

No of Reports

1              clozapine

109

2              venlafaxine

50

3              paroxetine

41

4              fluoxetine

35

5              paracetamol

29

6              bupropion

26

= 7           citalopram

24

= 7           zopiclone

24

9              olanzapine

19

= 10         dothiepin

18

= 10         sertraline

18

12            tramadol

16

13            quetiapine

14

14            amitriptyline

13

= 15         aspirin

11

= 15         carbamazapine

11

= 15         diazepam

11

18            diamorphine

10

= 19         dihydrocodeine

8

= 19         risperidone

8

 

SUICIDAL IDEATION                                                      

 

Drug Substance

No of Rpts

 1             fluoxetine

125

2              bupropion

74

3              paroxetine

57

4              isotretinoin

18

5              mefloquine

17

= 6           citalopram

11

= 6           efavirenz

11

= 6           mirtazapine

11

= 6           sertraline

11

= 6           venlafaxine

11

11            zopiclone

8

= 12         medroxyprogesterone

7

= 12         oestradiol

7

= 12         topiramate

7

= 15         levonorgestrel

6

= 15         nefazadone

6

= 15         norethisterone

6

= 15         simvastatin

6

= 19         amlodipine

5

= 19         atenolol

5

= 19         clarithromycin

5

= 19         etoricoxib

5

= 19         fluvoxamine

5

= 19         gabapentin

5

= 19         lamotrigine

5

= 19         levetiracetam

5

= 19         rofecoxib

5

 

 

 
 
< Prev   Next >
[ Back ]
(C) 2012 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]